Clinical Trial Site
At UCLA, our goal is to provide the best patient experience with every patient, every encounter, every time. For more than 60 years, UCLA Health has provided the best in health care and the latest in medical technology to the people of Los Angeles and throughout the world. Our mission is to deliver leading-edge patient care, research, and education.
UCLA Radiology is committed to providing outstanding patient care by combining excellence in clinical imaging, research, and educational programs with state-of-the-art technology.
UCLA Health offers the TULSA Procedure via the TACT 2.0 Clinical Trial and commercially. For the UCLA Health TACT 2.0 Clinical Trial, patients are only being treated for whole gland prostate ablation, but patients who do not meet the clinical trial eligibility can still pursue getting the TULSA Procedure within the commercial setting.
Prospective patients can read the study description and all details on patient eligibility for this trial on the ClinicalTrials.gov website.
Director of Prostate MR Imaging and Interventions
Dr. Raman is an expert in abdominal and pelvic imaging and interventional radiology, especially in the area of tumor ablation. He has been the founding member of the UCLA Prostate Imaging Group, whose members include physicians and scientists dedicated to advancing the field of prostate imaging. Dr. Raman believes that MR imaging the best non-invasive solution for finding the most aggressive prostate cancer.
Assistant Professor of Radiology
Professor of Radiology
Chief of Cross Sectional Interventional Radiology
Director of CT, High Intensity Focused Ultrasound Program and UCLA Liver Tumor Ablation Program
Global Head Office Locations
6, 2400 Skymark Avenue
Mississauga, ON
L4W 5K5
359, 9160 Forum Corporate Parkway
Fort Myers, FL
33905
Germany
Kehrwieder 9, 20457, Hamburg
Finland
Äyritie 4B, 01510, Vantaa